Follistatin-344
Unapproved myostatin-pathway research agent — not FDA-approved.
What it's for
Unapproved myostatin-pathway research agent — not FDA-approved.
What it's for
Follistatin-344 is an isoform of follistatin, a glycoprotein that binds and neutralizes activins and myostatin.
What it does for the body
Researched for increasing muscle mass by blocking myostatin/activin signaling. Not an approved medicine; research-chemical ‘FST-344’ injections are unapproved. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
It can trap myostatin and related activin signals — the body's usual "don't grow too much muscle" messages — so those signals are less able to limit muscle growth inside cells. This remains research-only, not an approved therapy.
Research context
Bottom line for readers: Follistatin-344 is best treated as a research-interest topic. Early papers can be fascinating; they are not a green light for self-experimentation.
Studied for (literature interest)
- Bones research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Follistatin-344 — FDA.gov search
- ClinicalTrials.gov search: Follistatin-344 — U.S. clinical trials registry
- Drugs@FDA search: Follistatin-344 — FDA drug database (if approved)
- PubMed search: Follistatin-344 — NCBI PubMed
- PubMed Central search: Follistatin-344 — NCBI PMC